Cybin: Regulatory Tailwinds Unlock Asymmetric Upside (Rating Upgrade) (NASDAQ:HELP)
Summary
Cybin Inc. is upgraded to Buy, driven by recent regulatory and clinical tailwinds that favor its lead candidate, HLP003. Learn more about HELP stock here.
Description
Cybin Inc. is upgraded to Buy, driven by recent regulatory and clinical tailwinds that favor its lead candidate, HLP003. Learn more about HELP stock here.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source